Bausch Health Companies (BHC) EPS (Diluted) Growth (5y) (2014 - 2026)
Bausch Health Companies (BHC) EPS (Diluted) Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.30% |
| Mar 31, 2026 | -17.67% |
| Dec 31, 2025 | 8.62% |
| Sep 30, 2025 | 19.42% |
| Jun 30, 2025 | 18.88% |
| Mar 31, 2025 | 11.56% |
| Dec 31, 2024 | 15.57% |
| Sep 30, 2024 | -12.42% |
| Jun 30, 2024 | 64.61% |
| Mar 31, 2024 | -7.24% |
| Dec 31, 2023 | 33.35% |
| Sep 30, 2023 | -0.98% |
| Jun 30, 2023 | 15.21% |
| Mar 31, 2023 | 39.94% |
| Dec 31, 2022 | -22.66% |
| Sep 30, 2022 | -21.38% |
| Jun 30, 2022 | -28.73% |
| Mar 31, 2022 | -16.02% |
| Dec 31, 2021 | 16.38% |
| Sep 30, 2021 | 16.55% |